Oral bisphosphonates and cancer risk, findings conflicting

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2011年 / 1362卷 / 1期
关键词：
Public Health; Osteoporosis; Cohort Study; Cancer Risk; Epidemiological Study;
D O I：
10.2165/00128415-201113620-00004
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [21] Risk of Esophageal or Gastric Cardia Cancer in Elderly Medicare Beneficiaries Treated with Oral Bisphosphonates
    Graham, David J.
    Howery, Andrew E.
    Major, Jacqueline M.
    Xie, Diqiong
    Bipat, Vedita
    Moeny, David
    Voss, Stephen
    Young, Jessica
    Lan, Ling
    MaCurdy, Thomas E.
    Worrall, Chris
    Kelman, Jeffrey A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 30 - 31
  • [22] Oral Bisphosphonates and Risk of Esophageal Cancer: A Dose-Intensity Analysis in a Nationwide Population
    Ho, Yunn-Fang
    Lin, Jaw-Town
    Wu, Chun-Ying
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (06) : 993 - 995
  • [23] Use of Oral Bisphosphonates and Risk of Colorectal Cancer: A Systemic Review and Meta-Analysis
    Thosani, Nirav
    Thosani, Sonali
    Kumar, Sheetanshu
    Nugent, Zoann
    Jimenez, Camilo
    Singh, Harminder
    Guha, Sushovan
    GASTROENTEROLOGY, 2012, 142 (05) : S402 - S402
  • [24] Low persistency with oral bisphosphonates in cancer patients
    Hoer, A.
    Gothe, H.
    Barghout, V.
    Schiffhorst, G.
    Haeussler, B.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2006, 10 (03) : 220 - 221
  • [25] Persistency with oral bisphosphonates in cancer patients.
    Göl, D
    Höer, A
    Schiffhorst, G
    Brandman, J
    Häussler, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 783S - 783S
  • [26] Oral Bisphosphonates and Improved Survival of Breast Cancer
    Rennert, Gad
    Pinchev, Mila
    Gronich, Naomi
    Saliba, Walid
    Flugelman, Anath
    Lavi, Idit
    Goldberg, Hadassah
    Fried, Georgeta
    Steiner, Mariana
    Bitterman, Arie
    Landsman, Keren
    Rennert, Hedy S.
    CLINICAL CANCER RESEARCH, 2017, 23 (07) : 1684 - 1689
  • [27] Interview: Breast cancer therapy with oral bisphosphonates
    Roche
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (11) : 1286 - 1286
  • [28] Use of Bisphosphonates and Risk of Breast Cancer
    Peter Vestergaard
    Lone Fischer
    Marco Mele
    Leif Mosekilde
    Peer Christiansen
    Calcified Tissue International, 2011, 88 : 255 - 262
  • [29] Exposure to bisphosphonates and risk of colorectal cancer
    Singh, Harminder
    Nugent, Zoann
    Demers, Alain
    Mahmud, Salaheddin
    Bernstein, Charles
    CANCER, 2012, 118 (05) : 1236 - 1243
  • [30] Use of Bisphosphonates and Risk of Breast Cancer
    Vestergaard, Peter
    Fischer, Lone
    Mele, Marco
    Mosekilde, Leif
    Christiansen, Peer
    CALCIFIED TISSUE INTERNATIONAL, 2011, 88 (04) : 255 - 262
12345